Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_assertion type Assertion NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_head.
- NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_assertion description "[Our pooled analysis revealed that the EML4-ALK fusion gene was observed predominantly in adenocarcinoma, non-smoking and NSCLC patients, especially those diagnosed in the advanced clinical stage of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_provenance.
- NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_assertion evidence source_evidence_literature NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_provenance.
- NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_assertion SIO_000772 25706305 NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_provenance.
- NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_assertion wasDerivedFrom befree-2016 NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_provenance.
- NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_assertion wasGeneratedBy ECO_0000203 NP1265704.RASS7Yg___1HSMtH1noQzaMvWgNXPk_NzCuFW7gT6Ky1Q130_provenance.